Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Adaptimmune Therapeutics

    NASDAQ: ADAP · Real-Time Price · USD
    0.28
    -0.00 (-1.06%)
    At close: Jun 09, 2025, 3:58 PM

    Adaptimmune Therapeutics Revenue

    Adaptimmune Therapeutics reported an annual revenue of $178.03M, reflecting a 195.34% growth. For the quarter ending March 31, 2025, Adaptimmune Therapeutics generated $7.29M in revenue.
    Revenue (ttm)
    $178.03M
    Revenue Growth
    195.34%
    Price / Sales Ratio
    0.76
    Revenue / Employee
    $351.84K
    Employees
    506
    Market Cap
    72.84M

    Revenue Chart

    Revenue History

    Fiscal Year End Revenue % Change
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist